| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/7854_2014_311 |
| P698 | PubMed publication ID | 24850078 |
| P50 | author | Darren J Moore | Q87693446 |
| P2093 | author name string | Guillaume Daniel | |
| P2860 | cites work | Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism | Q24309753 |
| Disease-specific induced pluripotent stem cells | Q24641981 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors | Q28749672 | ||
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 331-368 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Current topics in behavioral neurosciences | Q26842118 |
| P1476 | title | Modeling LRRK2 Pathobiology in Parkinson's Disease: From Yeast to Rodents | |
| P478 | volume | 22 |
| Q99711175 | A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2 |
| Q57143848 | Animal models of neurodegenerative diseases |
| Q39137358 | Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation. |
| Q39206443 | Models of LRRK2-Associated Parkinson's Disease |
| Q35999331 | Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression. |
| Q95934172 | The effect of LRRK2 loss-of-function variants in humans |
| Q37513500 | The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research |
| Q39206431 | Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity. |
| Q33708940 | VPS35, the Retromer Complex and Parkinson's Disease. |
Search more.